Raffles Medical Group Ltd
RAFLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $752 | $708 | $823 | $724 |
| % Growth | 6.1% | -14% | 13.7% | – |
| Cost of Goods Sold | $265 | $392 | $127 | $143 |
| Gross Profit | $486 | $316 | $640 | $581 |
| % Margin | 64.7% | 44.6% | 77.8% | 80.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $137 | $104 | $0 |
| SG&A Expenses | $0 | $142 | $104 | $42 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $404 | $58 | $101 | $416 |
| Operating Expenses | $404 | $200 | $205 | $458 |
| Operating Income | $82 | $116 | $196 | $121 |
| % Margin | 11% | 16.3% | 23.8% | 16.8% |
| Other Income/Exp. Net | $4 | $4 | -$4 | -$6 |
| Pre-Tax Income | $87 | $119 | $192 | $116 |
| Tax Expense | $25 | $28 | $48 | $32 |
| Net Income | $62 | $90 | $143 | $84 |
| % Margin | 8.3% | 12.7% | 17.4% | 11.6% |
| EPS | 0.034 | 0.049 | 0.077 | 0.045 |
| % Growth | -30.9% | -37.3% | 71.4% | – |
| EPS Diluted | 0.033 | 0.048 | 0.077 | 0.045 |
| Weighted Avg Shares Out | 1,857 | 1,859 | 1,857 | 1,868 |
| Weighted Avg Shares Out Dil | 1,861 | 1,869 | 1,866 | 1,876 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $10 | $3 | $1 |
| Interest Expense | $6 | $6 | $7 | $6 |
| Depreciation & Amortization | $43 | $25 | $39 | $39 |
| EBITDA | $136 | $133 | $236 | $161 |
| % Margin | 18.1% | 18.8% | 28.7% | 22.3% |